On July 15, the Ministry of Health presented the first National Strategy for evaluation Clinical evaluation Medicinal Products in ČR (NS KHLP 2035) at a press conference. This is phase significant phase developing a modern, transparent, and competitive environment for conducting clinical evaluation
On July 1, 2026, the European Partnership for Rare Diseases (ERDERA) announced a new call for proposals, the Clinical Trial Call 2026 (ECTC). The call supports transnational early-phase interventional clinical trials in the field of rare diseases that are conducted in accordance with the principles of Good Clinical Practice (Good Clinical…
Effective June 16, 2026, Ing. Iva Škach Vrbíková was ČR Director of the Office of the ČR Health Research Agency. She succeeds Bc. Martin Suchý, who has left the agency. Ing. Iva Škach Vrbíková previously served as…
Czech health research achieves above-average results in international comparisons, even though the government invests significantly less in it than most developed European countries. This is shown by an interim evaluation of the Program to Support Applied Health Research for 2024–2030, which was conducted for the Health Research Agency…
On June 3, 2026, the European Rare Diseases Research Alliance (ERDERA) published a notice regarding the new Clinical Trial Call 2026 (ECTC), which will be launched on July 1, 2026. This call will support transnational Phase I and Phase I/II interventional clinical trials…
We have prepared this year’s first issue of the ČR Health Research Agency newsletter, which summarizes the most important events of the past few months. We are very pleased that interest in the public call for proposals continues to grow significantly. Compared to last year, the number of project proposals submitted…
The Ministry of Health / the ČR Health Research Agency ČR joined the so-called Widening Process following the first round of the transnational THCS (Transforming Health and Care System) partnership call: “Access to Care 2026.” What is the Widening Process? In the second round of the EP THCS call, Czech researchers…
The Ministry of Health / ČR Health Research Agency ČR the so-called Widening Process following the first round of the transnational call for proposals under the European Partnership for Personalised Medicine (EP PerMed): Personalised Medicine for CARdiovascular, MEtabolic, and Kidney Diseases (“CARMEN 2026”). What is the Widening Process? In the second round of the call…
The Ministry of Health (hereinafter referred to as “MoH”) is announcing on April 29, 2026, in accordance with Act No. 130/2002 Coll., on the Support of Research and Development from Public Funds and on Amendments to Certain Related Acts (the Act on the Support of Research and Development), as amended (hereinafter referred to as the “Act”),…
The document “Common Errors in the National Mandatory Annex to the Application Form,” which was first published last year, has now been updated. The new version provides more detailed instructions on how to complete the form correctly, including basic information, the involvement of Czech partners, and the financial aspects of the project. We therefore recommend that all applicants…